Abeona Therapeutics

-$0.02 (-1.61%) As of 12:59 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABEO and other ETFs, options, and stocks.

About ABEO

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB).

CEO
Michael Amoroso
Employees
76
Headquarters
New York, New York
Founded
1974

ABEO Key Statistics

Market Cap
125.52M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
474.87K
High Today
$1.27
Low Today
$1.21
Open Price
$1.24
Volume
371.54K
52 Week High
$3.79
52 Week Low
$0.9895

ABEO Earnings

-$0.52
-$0.35
-$0.17
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure